Document:

Exhibit

AMENDMENT NO. 1 TO SECTION 382 RIGHTS AGREEMENT
THIS AMENDMENT NO. 1 (the “Amendment”), dated as of February 28, 2019, to the Section 382 Rights Agreement (the “Rights Agreement”), dated as of October 23, 2018, between Mitek Systems, Inc., a Delaware corporation (the “Company”), and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent (the “Rights Agent”, which term shall include any successor rights agent hereunder), is being executed at the direction of the Company.  
WHEREAS, Section 27 of the Rights Agreement permits the Company from time to time to supplement and amend the Rights Agreement as set forth therein.  
NOW, THEREFORE, in consideration of the foregoing and the agreements, provisions and covenants herein contained, the parties hereto agree as follows:  
1.Amendment to Rights Agreement. 
(a)    Section 1 of the Rights Agreement is hereby amended to add the following defined terms: 
 “Exemption Request” has the meaning set forth in Section 36. 
“Requesting Person” has the meaning set forth in Section 36. 
(b)    The defined term “Beneficial Owner”, “Beneficially Own” and “Beneficial Ownership” in Section 1(d) of the Rights Agreement is hereby deleted in its entirety and is replaced with the following:
“A Person shall be deemed the “Beneficial Owner” of and shall be deemed to “Beneficially Own,” or have “Beneficial Ownership” of, any securities:
(i)which such Person actually owns (directly or indirectly) or would be deemed to actually or constructively own pursuant to Section 382 of the Code and the Treasury Regulations promulgated thereunder (including any coordinated acquisition of securities by any Persons Acting in Concert (to the extent ownership of such securities would be attributed to such Persons under Section 382 of the Code and the Treasury Regulations promulgated thereunder)); or
(ii)    which are Beneficially Owned (within the meaning of the preceding clauses of this paragraph (d)), directly or indirectly, by any other Person (or any Affiliate or Associate of such Person) with which such Person (or any of such Person’s Affiliates or Associates) has any agreement, arrangement or understanding, whether or not in writing, for the purpose of acquiring, holding, voting or disposing of any securities of the Company or cooperating in obtaining, changing or influencing the control of the Company; provided that the effect of such agreement, arrangement or understanding is to treat such Person as an “entity” under Section 1.382-3(a)(1) of the Treasury Regulations.
Notwithstanding anything in this definition of Beneficial Owner to the contrary, the phrase “then outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, means the number of such securities then issued and outstanding together with the number of such securities not then actually issued and outstanding which such Person would be deemed to Beneficially Own hereunder.
Notwithstanding anything in this Agreement to the contrary, to the extent not within the foregoing provisions of this paragraph (d), a Person shall be deemed the “Beneficial Owner” of, and shall be deemed to “beneficially own” or have “beneficial ownership” of, any securities which such Person would be deemed to constructively own or which would be aggregated with shares owned by such Person pursuant to Section 382 of the Code, or any successor provisions or replacement provision and the Treasury Regulations thereunder.”

1    

 (c)    A new Section 36, entitled “Process to Seek Exemption,” is hereby added to the Rights Agreement as follows:  
“Section 36.   Process to Seek Exemption. Any Person who desires to effect any acquisition of securities that would, if consummated, result in such Person becoming an Acquiring Person (a “Requesting Person”) may, prior to such time and in accordance with this Section 36, request that the Board grant an exemption with respect to such acquisition under this Agreement so that such Person would be deemed to be a “Grandfathered Stockholder” as defined in Section 1 for purposes of this Agreement (an “Exemption Request”). An Exemption Request shall be in proper form and shall be delivered to the Company in accordance with the notice provisions of Section 26 of this Agreement. The Exemption Request shall be deemed made upon confirmed receipt by the Company. To be in proper form, an Exemption Request shall set forth (a) the name and address of the Requesting Person, (b) the number and percentage of Common Shares then Beneficially Owned by the Requesting Person, together with all Affiliates and Associates of the Requesting Person, and (c) a reasonably detailed description of the transaction or transactions by which the Requesting Person would propose to become an Acquiring Person and the maximum number and percentage of Common Shares that the Requesting Person proposes to acquire. The Board, or a duly constituted committee of independent directors, shall make a determination whether to grant an exemption in response to an Exemption Request as promptly as practicable (and, in any event, within ten (10) Business Days) after receipt thereof; provided, that the failure of the Board (or any such committee) to make a determination within such period shall be deemed to constitute the denial by the Board of the Exemption Request. The Requesting Person shall respond promptly to reasonable and appropriate requests for additional information from the Board and its advisors to assist the Board in making its determination. The Board, or a duly constituted committee of independent directors, shall only grant an exemption in response to an Exemption Request if the Board determines in its sole discretion, or such committee determines in its sole discretion, that the acquisition of Beneficial Ownership of Common Shares by the Requesting Person, considered alone or with other transactions (including past transactions or contemplated transactions), (i) will not jeopardize or endanger the Tax Benefits of the Company, taking into account such facts and circumstances as the Board (or any such committee) reasonably deems relevant or (ii) is otherwise in the best interests of the Company. Any exemption granted hereunder may be granted in whole or in part, and may be subject to limitations or conditions (including a requirement that the Requesting Person agree that it will not acquire Beneficial Ownership of Common Shares in excess of the maximum number and percentage of shares approved by the Board), in each case, as and to the extent the Board, or a duly constituted committee of independent directors, shall determine necessary or desirable to provide for the protection of the Tax Benefits or as is otherwise in the best interests of the Company. The Exemption Request shall be considered and evaluated by the Board, or a duly constituted committee of independent directors, and the action of a majority of such directors (or such committee) shall be deemed to be the determination of the Board for purposes of such Exemption Request.” 
2.    Officer’s Certificate. By executing this Amendment below, the undersigned duly appointed officer of the Company certifies that this Amendment has been executed and delivered in compliance with the terms of Section 27 of the Rights Agreement.
3.    Interpretation. The term “Agreement” as used in the Rights Agreement shall be deemed to refer to the Rights Agreement as amended hereby, and all references to the Rights Agreement shall be deemed to include this Amendment.  
4.    Waiver of Notice. The Rights Agent and the Company hereby waive any notice requirement under the Rights Agreement pertaining to the matters covered by this Amendment. 
5.    Effectiveness. Upon the delivery of the executed counterparts to this Amendment, this Amendment shall become effective as of the date first written above.  Except as modified by this Amendment, the Rights Agreement shall remain in full force and effect without any modification.  
6.    Severability. If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment, and of the Rights Agreement, shall remain in full force and effect and shall in no 

2

way be affected, impaired or invalidated; provided, however, that if such invalid, void or unenforceable provision affects the rights, immunities, duties or obligations of the Rights Agent under the Rights Agreement, as amended hereby, then the Rights Agent shall be entitled to resign immediately upon written notice to the Company.
7.    Governing Law. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and performed entirely within such State.
8.    Counterparts. This Amendment may be executed in several counterparts, each of which shall constitute an original and all of which, when taken together, shall constitute one agreement.  A signature to this Amendment executed and/or transmitted electronically shall have the same authority, effect and enforceability as an original signature.

3

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the day and year first written above.
	
		
	 
	MITEK SYSTEMS, INC.

	 
	 

	 
	By:   /s/ Jason Gray             

	 
	Name:   Jason Gray 
Title:     General Counsel

	 
	 

	 
	 

	 
	 

	 
	COMPUTERSHARE TRUST COMPANY, N.A.

	 
	 

	 
	 

	 
	By:   /s/ Patrick Hayes             

	 
	Name:   Patrick Hayes 
Title:     Vice President & ManagerExhibit

EXHIBIT 10.7

Amendment No. 1
Pfizer Consolidated Supplemental Pension Plan for United States and Puerto Rico Employees
(Amended and Restated December 31, 2016)

*     *     *

A new Appendix I is added to the end of “Part B: Provisions Applicable To The Pfizer Sub-Plan” of the Pfizer Consolidated Supplemental Pension Plan for United States and Puerto Rico Employees to read as follows:

1

APPENDIX I

SUPPLEMENTAL PRAP VOLUNTARY EARLY RETIREMENT PLAN

ARTICLE I

Purpose

SECTION 1.1    

This Appendix I contains the Supplemental PRAP Voluntary Early Retirement Plan (the "VERP/SSP SERP"), a Subplan to the Plan, which is being adopted in order to provide a pension enhancement to certain members of the Retirement Plan who are U.S. employees of Pfizer Inc., and who elect to be included in the Voluntary Early Retirement Program (the “VERP”), or who are involuntarily terminated in connection with the new Organizing for Growth (“OFG”) operating model and receive the Special Separation Program (“SSP”) enhanced benefits under either the Pfizer Separation Plan, the Senior Leadership Council Separation Plan or the Executive Severance Plan (the “OFG U.S. Program”).

ARTICLE II

Definitions

SECTION 2.1.    

Whenever used herein, unless the context otherwise indicates, the following terms shall have the respective meanings as set forth below or as defined in Part A of the Plan:
        
Administrative Committee:  the Administrative Committee of the Company.
     
Calculation Date: the first day of the month coincident with or next following the later of (1) the date the Participant attains age 55 (or the date the Participant would have attained Rule of 90 if he or she had remained employed, if earlier) or (2) the date of the Participant’s Separation from Service.
Coordinating Office or Separation Coordinating Office: the staff designated by the Plan Administrator to handle claims for benefits under the VERP and the OFG U.S. Program.  

Election Period: the period of time in which an eligible Employee may elect to participate in the VERP.

Employee: any person who is a regular full-time or part-time employee of Pfizer Inc. or one of its affiliates in one of the 50 states or the District of Columbia, or an employee paid from the United States under the Pfizer International Assignment Policy, and in each case such employee is on U.S. payroll and participating in U.S. benefits. Employees working for a Pfizer legal entity based in Puerto Rico are excluded from participating in the VERP/SSP SERP. 

OFG U.S. Program: the enhanced involuntary severance program established in connection the new OFG operating model which consists of enhanced benefits under this VERP/SSP SERP, the Retirement Plan, the Pfizer Inc. Retiree Medical Plan, the Pfizer Inc. Health and Insurance Plan, the Pfizer Savings Plan, the Pfizer Supplemental Savings Plan, and with respect to a Participant’s annual equity awards, and severance benefits under either the Pfizer Separation Plan, the Senior Leadership Council Separation Plan or the Executive Severance Plan.

2

Participant: a person who is eligible for participation in the VERP/SSP SERP under the provisions of Appendix I; Article III.

Payment Date: the date described in Appendix I; Section 4.2 below.

PRAP: the Pfizer Retirement Annuity Plan which is contained in Part B of the Retirement Plan.
        
Separation Date or Separation from Service or Separate(s) from Service: a Participant’s date of termination which shall constitute a "separation from service" within the meaning of Code section 409A. With respect to an OFG Participant separated under the VERP, the Separation Date shall be the OFG Participant’s date of termination, which shall be December 31, 2018 unless otherwise deferred by the Company.  With respect to an OFG Participant separated under the SSP, the Separation Date shall be the OFG Participant’s date of termination.
        
Supplemental VERP/SSP Plan Benefit: the amount of the benefit that a Participant is eligible to receive under this VERP/SSP SERP as described in Appendix I; Article IV.

VERP: the Voluntary Early Retirement Program established in connection the new OFG operating model which consists of enhanced benefits offered under this VERP/SSP SERP, the Retirement Plan, the Pfizer Inc. Retiree Medical Plan, the Pfizer Inc. Health and Insurance Plan, the Pfizer Savings Plan, the Pfizer Supplemental Savings Plan, and with respect to a Participant’s annual equity awards.

VERP/SSP SERP: this Subplan contained in this Appendix I to the Plan established in order to implement the enhanced pension benefits offered under the VERP and OFG U.S. Program.

VERP/SSP SERP Benefit Commencement Date or VERP BCD: the first day of the month coincident with or next following the date as of which the Participant would first be eligible to retire after reaching either (a) attainment of age 55 and completion of 10 years of retirement eligibility service or (b) Rule of 90, as described in Part B of the Retirement Plan. If the addition of 5 points enables the Participant to reach both (a) age 55 with 10 years of service and (b) Rule of 90, the Participant’s VERP/SSP SERP Benefit Commencement Date shall be the date that corresponds to the more valuable benefit. 

ARTICLE III

Eligibility for Plan Benefit

SECTION 3.1.    An Employee shall be a Participant and eligible to receive a Supplemental VERP/SSP Plan Benefit under this VERP/SSP SERP in an amount determined in accordance with Appendix I; Article IV if he or she meets the following requirements: 

(a) he is an active Employee (including an Employee on short-term disability or a paid or unpaid leave of absence) who is a regular full-time or part-time employee of Pfizer Inc. or one of its affiliates in one of the 50 states or the District of Columbia, or an employee paid from the United States under the Pfizer International Assignment Policy, and in each case such employee is on U.S. payroll and participating in U.S. benefits; 

(b) he elects to be voluntarily terminated under the VERP during the Election Period, and he is eligible for, signs a release and does not revoke it, and receives benefits under the VERP or his employment is involuntarily terminated under the OFG U.S. Program and he signs a release and does not revoke it, and receives benefits under the OFG U.S. Program;

     (c) he has a Retirement Benefit under Part B of the Retirement Plan and the addition of five (5) points as of December 31, 2018 for a VERP Participant (including a VERP Participant who is re-classified as SSP subsequent to his termination of employment), or as of his Separation Date in the case of a Participant who is terminated under the SSP, to his age, service, or any combination thereof would enable him to qualify for subsidized early retirement because he would reach either (i) age 55 and completion of 10 years of retirement eligibility service or (ii) Rule of 90, as described in Part B of the Retirement Plan. Employees who have already 

3

reached either: (i) age 55 and completion of 10 years of retirement eligibility service; or (ii) Rule of 90, as described in Part B of the Retirement Plan as of their Separation Date, cannot benefit from the five (5) points;

(d) he has more than or equal to $235,000 in pensionable earnings under Part B of the Retirement Plan in 2017 or has an accrued benefit under Part B of the Plan; and

(e) he is not an Excluded Employee. For this purpose, an Employee is an Excluded Employee if any of the following applies:

		
	•
	The Employee’s terms and conditions of employment are subject to collective bargaining.

		
	•
	The Employee is or has been a Named Executive Officer in the Company’s Annual Proxy Statement.

		
	•
	The Employee is currently working for a Pfizer legal entity based in Puerto Rico.

		
	•
	The Employee is receiving benefits from a Company-sponsored long-term disability plan.

		
	•
	The Employee is on secondment in the United States.

		
	•
	The Employee is not paid through the U.S. payroll and/or is not eligible for U.S. benefits. 

		
	•
	The Employee has been deemed ineligible through the Claims and Appeals Procedure.

SECTION 3.2.    For the purposes of Appendix I; Section 3.1, with respect to a Participant who dies while in active service on or after his election to participate in VERP but before executing the release agreement, the spouse or the estate may sign the release agreement on his or her behalf, if applicable. 

ARTICLE IV

Supplemental VERP/SSP Plan Benefits

SECTION 4.1    If a Participant is eligible as determined in Appendix I; Article III, the Company shall make a lump sum cash payment to the Participant in an amount equal to the difference between (i) and (ii) below, discounted or increased if applicable from the Participant’s VERP/SSP SERP Benefit Commencement Date (“VERP BCD”) to the Participant’s Payment Date, using a discount rate equal to the first segment rate in Code Section 417(e)(3)(C), published in the third month prior to the Calculation Date, where:

(i) is the present value of the Participant’s accrued benefit under the PRAP portion of the Retirement Plan and the Plan, determined as of the VERP BCD, reflecting (a) the early retirement reduction factor that would apply if five (5) points were added to the Participant’s age, service, or a combination thereof as of December 31, 2018 (or as of his Separation Date in the case of a Participant whose employment is terminated under the OFG U.S. Program), and (b) without reference to the limitations of Code Sections 415 and 401(a)(17); 

(ii) is the present value of the Participant’s accrued benefit under the PRAP portion of the Retirement Plan and the Plan, determined as of the VERP BCD, without reflecting the 5-point enhancement described in (i) and without reference to the limitations in Code Sections 415 and 401(a)(17);

For purposes of (ii) above, in the event the Participant’s VERP BCD is prior to his attainment of age 55, the early retirement reduction applied to years below age 55 shall be the actuarial equivalent of the benefit at age 55, where actuarial equivalence is determined using an interest discount rate of 5% and mortality in accordance with Code Section 417(e).

4

The present values shall be calculated using the PRAP portion of the Retirement Plan’s actuarial assumptions for payment of lump sums as published in the third month prior to the Calculation Date. The five (5) point enhancement applies solely for the purpose of determining the reduction for early retirement, if any, with respect to the PRAP portion of the benefit; it does not count for any purpose with respect to benefit formulas, the computation of the Normal Retirement Benefit, or the computation of the lump sum factors. 

In the event the Participant has chosen a single life annuity as his payment election, the amount determined in Section 4.1 shall be converted to a life annuity using an immediate annuity factor determined as of the Participant’s Payment Date, determined using the Code Section 417(e)(3)(C) interest rate published in the third month prior to the Calculation Date and mortality table under Code Section 417(e) in effect as of the Participant’s Payment Date. 

SECTION 4.2.    Such lump sum payment shall be made as soon as practicable in the January coincident with or following the later of (1) such Participant’s Separation from Service, or (2) the Participant’s attainment of age 55 (or the date the Participant would have attained Rule of 90 if he or she had remained employed, if earlier), unless the Participant has an Accrued Benefit under Part B of the Plan in which case the Supplemental VERP/SSP Plan Benefit will be paid in accordance with the payment elections under Part B of the Plan. Notwithstanding the foregoing, payments may not be made to a Key Employee upon Separation from Service before the date which is six (6) months after the date of the Key Employee’s Separation from Service (within the meaning of Code section 409A). In the event that payment is delayed pursuant to the preceding sentence, payment shall be made (i) on the first day of the seventh month following the Key Employee’s Separation from Service (within the meaning of Code section 409A), or, (ii) if earlier, the first day of the month after such Participant’s death during this period of delay. The above shall define the Participant’s Payment Date regardless of whether due to administrative delays, the actual payment is made after the Payment Date. 
SECTION 4.3    If a Participant dies after becoming eligible to receive a Supplemental VERP/SSP Plan Benefit and prior to the Participant’s Payment Date, the following benefits are payable from the Plan in the form of a rollover to the Pfizer Supplemental Savings Plan in accordance with the provisions in Part B, Section 5.4 of the Plan, as if the Participant had died during active employment: 

(i) If the Participant is married at the time of death, and the Participant’s spouse waives the QPSA, the lump sum death benefit equal to the benefit determined in accordance with Appendix I; Section 4.1 of the VERP/SSP SERP shall be transferred to the PSSP account.

(II) If the Participant is married at the time of death and the spouse does not waive the QPSA, no benefit is payable from the VERP/SSP SERP. However, pre-retirement death benefits may be payable from the Retirement Plan and the Plan.

(iii) If the Participant is not married at the time of death, the lump sum death benefit equal to the benefit determined in accordance with Appendix I; Section 4.1 of the VERP/SSP SERP shall be transferred to the Participant’s Pfizer Supplemental Savings Plan account.

(iv) The lump sum death benefit shall be payable as of the January 1 coincident with or next following the Participant’s death. 

SECTION 4.4    If a Participant is rehired prior to the Participant’s Payment Date, the Participant shall be entitled to the VERP/SSP SERP Plan Benefit determined in accordance with Appendix I; Section 4.1, payable as of the Participant’s Payment Date, as if the Participant had not been rehired. The five (5) point enhancement may not be used towards any other milestone.

SECTION 4.5    The benefits payable under the VERP/SSP SERP are determined solely with respect to the PRAP formula and early retirement provisions in Part B of the Retirement Plan and the corresponding section in the Plan. Nothing in the VERP/SSP SERP shall be construed as changing retirement benefits corresponding to any legacy retirement plan benefit, other than PRAP benefits. 

5

ARTICLE V

Administration and Claims and Appeals Procedure

SECTION 5.1.    The Committee has delegated the ministerial authority to administer claims for benefits under the Plan to the Company’s Separation Coordinating Office or its successor. The Separation Coordinating Office is responsible for determining who is eligible to become a Participant and for determining initial claims for benefits under the VERP/SSP SERP.

SECTION 5.2.    The Committee has delegated authority to administer the appeal of denied claims under the VERP/SSP SERP to the Administrative Committee.  

SECTION 5.3.    Any request by a Participant or any other person for any benefit alleged to be due under the Plan shall be known as a “Claim” and the Participant or other person making a Claim, or the authorized representative of either, shall be known as a “Claimant.” To make a Claim, the Claimant must submit the Claim in writing to the Separation Coordinating Office. The Claim must include a description of the benefit that the Claimant believes is due, the reason(s) the Claimant believes such benefit is due and any information and documentation that the Claimant believes supports his Claim and that he wishes to have the Separation Coordinating Office consider.

SECTION 5.4.    The Coordinating Office will process the Claim within 90 days of receipt of the Claim unless special circumstances require an extension of time for determining the Claim. In such event, written notice of an extension of time to consider the Claim and the reasons for it, will be sent to the Claimant before the end of the initial 90-day period. The extension will not exceed a period of 90 days from the end of the initial 90-day period. If the Coordinating Office has not determined the Claimant’s eligibility for a Plan benefit within this 90-day period (180-day period if circumstances require an extension of time) the Claimant may deem the Claim denied.  

SECTION 5.5.    In the event a Claim is denied, in whole or in part, the notice of denial will set forth: (i) the specific reason(s) for the denial; (ii) specific reference to the pertinent Plan provisions on which the denial is based; (iii) a description of any additional material or information necessary for the Claimant to perfect the Claim and an explanation of why such material or information is necessary; and (iv) an explanation that, if an adverse determination is made on review, the Claimant has a right to bring a civil action under Section 502(a) of ERISA. 

SECTION 5.6.    Within 60 days of receipt of notice of a Claim that has been denied in whole or in part, or from the date that a Claim is deemed denied, the Claimant may (i) submit an appeal, which is a written request for review by the Administrative Committee that includes all information and documents that the Claimant wishes to have the Administrative Committee consider; and (ii) review documents pertinent to the Claim. The Claimant shall be provided upon request and free of charge, reasonable access to all documents and records and other information relevant to the Claim. If the Claimant does not request an appeal of the denied claim within the 60-day period, the Claimant shall be barred and estopped from challenging the denial.

SECTION 5.7.    The Administrative Committee will review a denied Claim for which an appeal has been submitted and render a decision no later than 60 days after receipt of the appeal, provided, however, that if special circumstances require an extension of time for determining the appeal, a decision shall be rendered no later than 120 days after receipt of the appeal. Written notice of any such extension and the reasons for it, shall be furnished to the Claimant before the end of the initial 60-day period. The extension will not exceed a period of 60 days from the end of the initial 60-day period. If the Administrative Committee has not rendered a decision within this 60-day period (120-day period if circumstances require an extension of time) the Claimant may deem the appeal denied.  

SECTION 5.8.    In the event an appeal is denied, in whole or in part, the Administrative Committee’s decision will set forth: (i) the specific reason(s) for the denial; (ii) specific reference to the pertinent VERP/SSP SERP provisions on which the denial is based; and (iii) an explanation that the Claimant has a right to bring a civil action under Section 502(a) of ERISA. 

SECTION 5.9.    No legal action may be brought for benefits under this VERP/SSP SERP until the Claimant has exhausted the administrative procedure described in this Article V. No legal action may be commenced at all unless commenced no later than one year following the issuance of a final decision on the Claim, or the expiration of the appeal decision period if no decision is issued. This one-year statute of limitations 

6

on suits for all benefits shall apply in any forum where the Claimant may initiate such a suit. 

SECTION 5.10.    No member of the Board of Directors or of the Committee, the Administrative Committee, the Separation Coordinating Office, or its delegates shall be liable for any act or action, whether of commission or omission, taken by any other member, or by any officer, agent or employee or by any investment advisor or financial institution appointed by any such person; nor, except in circumstances involving his bad faith, for anything done or omitted to be done by himself. Each member of the Committee, Administrative Committee, and Separation Coordinating Office shall be fully indemnified and entitled to receive an advance of any related attorney fees in connection with legal proceedings related to the Plan.

    
ARTICLE VI

Miscellaneous

SECTION 6.1.    Each Participant shall, after his Separation Date, make himself available for such consultative and advisory services as the Company may reasonably request, taking fairly into consideration the age, health, residence, and individual circumstances of the Participant, and provided such amount of services to be provided shall not prevent the Participant’s termination from constituting a Separation from Service. If such Participant shall unreasonably refuse to render such services, the Company may require such Participant to reimburse any payments made hereunder.

SECTION 6.2.    Any benefit hereunder which is unclaimed, including outstanding checks, may, as determined by the Retirement Committee, be forfeited.

SECTION 6.3.    The adoption of this Appendix allows for the early vesting of certain benefits under the Plan and shall not be considered a modification to the Plan. 

SECTION 6.4.    The Company reserves the right to delay the Separation Date of any Participant who elected to be included in the VERP for a period of up to six months (or until June 30, 2019) without the consent of the Participant. Further, provided the Participant consents, the Company may delay the Separation Date up to June 30, 2020.

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]